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Sørlandet Hospital in Norway has a history of offering patients with obsessive-
compulsive disorder (OCD) cognitive behavior group therapy using 12 weekly sessions
of 2.5 h each. A previous evaluation of this treatment has shown that 51.9% did not
respond at post-treatment. Recently, a highly concentrated group-treatment format, the
Bergen 4-day treatment (B4DT), has been shown to help more than 90% of patients
with OCD post-treatment. Based on these positive results, it was decided to explore
whether the B4DT could be a feasible format for delivering ERP at another clinic.
Thirty-five consecutively recruited patients were included in the current pilot study, and
assessed at pre-treatment, post-treatment, and 3-month follow-up. Treatment response
rate (35% reduction in OCD-symptom score) was 94% at post-treatment, and 80% at
follow-up. Seventy-four percent were in remission at post-treatment and 68% at follow-
up. Only one patient dropped out of treatment. The patients were highly satisfied with
the treatment content and format. The results indicate that the 4-day treatment could
successfully be implemented at a new clinic.
Keywords: obsessive-compulsive disorder, ERP, exposure therapy, B4DT, group therapy, outcome
INTRODUCTION
Obsessive Compulsive Disorder (OCD) is a debilitating disorder that tends to become chronic when
untreated (Skoog and Skoog, 1999). Since the late 1960’s, when Victor Meyer first published his
work (Meyer, 1966), it has been established that exposure and response prevention (ERP) is an
effective treatment approach that can be delivered in a number of formats (Olatunji et al., 2013),
for example individually (Foa et al., 2005), in a group setting (Jonsson and Hougaard, 2009), spread
over months (van Balkom et al., 1998) or concentrated (Hiss et al., 1994). When delivered in a
group format (d = 0.24), the effect sizes are generally lower, as compared to individually (d = 0.50)
delivered treatment (Öst et al., 2015).
Recently, results from a novel, ultra-concentrated format where the exposure-based treatment
is delivered during four consecutive days, namely the Bergen 4-day treatment (B4DT), has been
reported. The B4DT is delivered during four consecutive days to a group of 3–6 patients by the same
number of therapists, and is often described as “individual treatment delivered in a group setting.”
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Following B4DT, 94% of the patients have responded (Havnen
et al., 2014, 2017; Hansen et al., 2018a), and 68% were recovered at
1–4 years follow-up (Hansen et al., 2018a, 2019). In addition, the
approach has shown significant effects on comorbid depressive
symptoms as well as on generalized anxiety. The B4DT is highly
accepted by the patients and there are basically no dropouts
(Havnen et al., 2014, 2017; Hansen et al., 2018a; Kvale et al., 2018).
These results can be compared with those achieved by standard
ERP in the meta-analysis by Öst et al. (2015), where the response
rate was 65% and the remission rate 50% (while often using a
more lenient criterion than in the B4DT format studies above).
Our own clinic’s previous work when using a 12-week group CBT
approach showed that 51.9% did not respond at post-treatment
(Håland et al., 2010), which was an important reason for the
current pilot study with the B4DT.
The B4DT format was developed and introduced as part of
standard care in an ordinary outpatient clinical setting with
low selection of patients. The average duration of the OCD
in the published effectiveness studies was 15.7 years (Hansen
et al., 2019), and mean pre-treatment score on the Yale-Brown
Obsessive Compulsive Scale (Y-BOCS; Goodman et al., 1989b),
was 25.9 (Havnen et al., 2014, 2017; Hansen et al., 2018a). This
makes the B4DT highly relevant for outpatient units offering
treatment to patients with OCD.
Even though the B4DT is firmly rooted in ERP-treatment,
the format is new, and a recent meta-analysis (Open Science
Collaboration, 2015) of 100 replication studies in social-,
personality-, and cognitive psychology found that only 36% of the
studies replicated the results of the original studies, and the mean
effect size decreased from 0.40 to 0.20. The promising clinical
results seen following B4DT format makes it a highly relevant
approach that might substantially influence the way treatment
is delivered, if comparable results can be seen in new settings.
This is the first replication study reporting on the results of the
B4DT when delivered outside of the originators’ clinic to patients
seeking help in the public specialist mental health care, and we




In 2011, the Norwegian Health Authorities decided to establish
30 specialized OCD teams covering all health regions, with
the aim of providing evidence-based treatment to all patients
suffering from OCD (Kvale and Hansen, 2014). One of the
main purposes was to bridge the gap between what is known
as effective treatment for patients suffering from OCD, and
what the patients actually receive (Shafran et al., 2009). In
order to be able to monitor the effect of the treatment,
all teams were required to use a standardized protocol for
assessment and outcome measures. The current treatment was
delivered by the specialized OCD team at Sørlandet Hospital
(in the southern part of Norway) as part of ordinary care. On
initiative from the hospital, the data collection, with the aim
of summarizing the treatment outcome, was approved by the
local data protection agency (“Personvernombudet” and “Norsk
Samfunnsvitenskapelig Datatjeneste, NSD). When of interest for
a broader audience than the hospital, results are encouraged by
the hospital to be published in peer-reviewed journals.
The psychiatric outpatient clinic has a specialized team for
treating patients with OCD. All patients with OCD from a
catchment area of 290,000 are referred to this clinic, and if they
fulfill the diagnostic criteria of OCD with a severity indicating
need of treatment (score of 16 or more on Y-BOCS) they
are offered treatment. It is, however, important to note that if
patients are suicidal, psychotic, bipolar in an unstable phase,
actively substance abusing or have an eating disorder with a BMI
considered to be too low for initiating psychological treatment,
these disorders have to be dealt with before psychological
treatment for the OCD is initiated. All referred patients are
assessed in a face-to-face interview by one of the therapists of
the OCD-team. A total of 52 consecutively referred patients,
with treatment demanding OCD, were referred to the clinic from
October 2015 to September 2016. Two patients were suicidal, one
suffered from an ongoing bipolar disorder, one had an ongoing
drug abuse, and one suffered from an eating disorder that needed
to be dealt with prior to any OCD-treatment. Six of the referred
patients did not want any kind of exposure-based treatment.
Among the 41 patients that were eligible for OCD-treatment, two
patients were not fluent in Norwegian, and could due to this not
participate in the B4DT, and one lived too far from the clinic to
enable exposure in the home setting while participating in the
group. These three patients were offered individual treatment.
Of the 38 patients who were offered participation in the B4DT,
one did not want to participate in a group. Furthermore, one
patient who was offered and wanted the B4DT moved to another
part of the country before the treatment was initiated. Thus, 36
patients (10 men) were included in the B4DT groups. One patient
dropped out on day 2 of the treatment, due to unwillingness to
go on with exposure treatment, thus 35 of 36 patients completed
the treatment. Twenty-five of these 36 were women (71%). The
sample had a mean age of 30.43 (SD = 7.92). Thirty of the patients
(85.7%) had received previous treatment. For details related to
comorbidity and demographics, please refer to Table 1.
Primary and Secondary
Outcome Measures
Primary treatment outcome was changes in Y-BOCS scores.
Treatment response and remission were defined using a
modification of the international consensus criteria (Mataix-Cols
et al., 2016). Response is defined as a ≥35% reduction of the
individual patient’s pre-treatment Y-BOCS score, and remission
as the response criterion is fulfilled and the post-treatment
Y-BOCS score is ≤12 points. Changes in OCD-severity were also
measured by self-reports, as were secondary outcomes, namely
symptoms of generalized anxiety and depression.
Assessment
Patients were diagnosed at pre-treatment by an experienced
OCD-therapist using the Mini-International Neuropsychiatric
Interview (Sheehan et al., 1998). Before the B4DT groups,
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TABLE 1 | Demographics and diagnostic characteristics of the sample (N = 35).
n (%) N (%)
Female gender 25 (71.4%) Comorbidity (any disorder) 24 (68.6%)
Marital status Depression 9 (25.7%)
Single 14 (40.0%) Panic 8 (22.9%)
Cohabitant 21 (60.0%) Social anxiety disorder 8 (22.9%)
Previous treatment GAD 7 (20.0%)
Inpatient 6 (17.1%) ADHD 4 (11.4%)
Outpatient 30 (85.7%) PTSD 3 (8.6%)
Psychotropic drugs 14 (40.0%) Bipolar-II 1 (2.9%)
Education Specific phobia 1 (2.9%)





Not working/Sick leave 17 (48.6%)
Twelve of the 14 patients using psychotropic drugs used SSRIs, while two
used hypnotics. GAD, generalized anxiety disorder; PTSD, post-traumatic stress
disorder; ADHD, attention deficit hyperactivity disorder.
Y-BOCS (Goodman et al., 1989b) and the OCD-module in SCID-
I for DSM-5 (First et al., 2015) were conducted by specially
trained and independent assessors. The training of the assessors
consisted of theoretical lessons as well as video demonstrations
that illustrated different scores on the different items. This was
followed by a rating of three videotapes where they had to
demonstrate a minimum of 80% accuracy compared to an expert
on 2/3 of the interviews in order to proceed. On SCID-I, a kappa-
value of 0.80 and on Y-BOCS a maximum difference of ±2 points
were employed. Then the assessor had to perform three live
interviews with OCD-patients, which were videotaped and rated
by a blinded expert (same requirements as above).
Instruments
Mini-International Neuropsychiatric Interview (Sheehan et al.,
1998) is a structured diagnostic psychiatric interview for DSM-
IV and ICD-10. It has high concordance with other diagnostic
instruments (Sheehan et al., 1998).
Structural Clinical Interview for DSM Disorders (SCID-5; First
et al., 2015) covers Axis I psychiatric disorders according to
DSM-5. SCID has high inter-rater reliability with Cohen’s kappa
coefficients ranging 0.70–1.00.
The Yale-Brown Obsessive Compulsive Scale (Y-BOCS;
Goodman et al., 1989b) interview version consists of 10 items
covering the severity of obsessions and compulsions. The
Y-BOCS has good psychometric properties (Goodman et al.,
1989a,b). Scores range from 0 to 40 with higher scores indicating
higher severity.
The Dimensional Obsessive-Compulsive Scale-Short Form
(DOCS-SF; Eilertsen et al., 2017) is a 5-item self-report
questionnaire similar in structure to the original DOCS. Patients
indicate on a checklist if they experience any of the four presented
obsessions (contamination, responsibility, unacceptable thoughts
and symmetry/ordering, or “other”). The five items pertain
to severity (0–8 scale) of their obsessions and compulsions
during the last week. As with the Y-BOCS, DOCS-SF scores
range from 0 to 40.
The Obsessive-Compulsive Inventory Revised (OCI-R; Foa
et al., 2002) is an 18-item self-report inventory. OCI-R examines
severity of obsessive-compulsive symptoms. Each item is rated
on a 5-point Likert scale (0 = not at all, 4 = extremely), with
a total score range of 0–72. The total score of the OCI-R
provides information about the OCD severity, and there are
subscales addressing the severity of different types of obsessions
and compulsions: Washing, checking, obsessions, neutralizing,
ordering and hoarding. The OCI-R has been shown to be a valid
and reliable assessment tool (Foa et al., 2002; Solem et al., 2010).
The Patient Health Questionnaire 9-item (PHQ-9; Kroenke
et al., 2001) is based on nine criteria for diagnosing depression
in DSM-IV. Each item is rated on a four-point Likert scale
(0 = not at all, 3 = almost every day), and the answers refer to
the past 2 weeks. It has good reliability and validity (Kroenke
et al., 2010), and suggested cut-off score for detecting major
depressive disorder has varied from 8 to 11 in different studies
(Manea et al., 2012).
The Generalized Anxiety Disorder 7-item (GAD-7; Spitzer
et al., 2006) is based on the DSM-IV criteria for generalized
anxiety disorder. Each item is reported on a four-point Likert
scale (0 = not at all, 3 = almost every day), and the answers refer to
the past 2 weeks. It has good reliability and validity (Spitzer et al.,
2006), and suggested cut-off score for identifying GAD has varied
from 7 to 10 in different studies (Plummer et al., 2016).
Client Satisfaction Questionnaire 8 (CSQ-8; Nguyen et al.,
1983) is an 8-item questionnaire which measures patient
satisfaction with health services. Each item is scored from 1
(very low satisfaction) to 4 (very high satisfaction), and total
score ranges from 8 to 32. The CSQ-8 has sound psychometric
properties (Larsen et al., 1979; Nguyen et al., 1983).
Treatment
Prior to the treatment, patients are given a detailed description
of the outline of the treatment, and are asked to have no other
appointments during the 4 days. A modified version of the
Treatment expectancy questionnaire (Borkovec and Nau, 1972)
is used, in which the patients rate on a 0–100 scale (a) How much
the treatment approach makes sense, (b) Whether they would
recommend it to a friend, (c) How likely it is that they will show
up and engage fully in the treatment all 4 days, and (d) Whether
they expect the treatment to have the desired effect. If they rate
less than 70, this is taken as an opportunity to explore potential
obstacles for successful treatment. They are also asked to prepare
exposure tasks, and it is underscored that the exposures that the
OCD likes the least, are often the most useful. Also, they are
informed that it is most beneficial to start with the exposures
that are likely to make the largest changes in their life. On the
first day the group meets for approximately 4 h. The participants
give a brief presentation of themselves, and group norms of how
to best support each other are established. Then the patients as
a group are given a presentation about OCD and how to do
ERP. In the psychoeducation the importance of making fully
use of the three coming days in order get the OCD out if their
lives is emphasized. Also, the OCD is systematically externalized
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and described in negative terms as something craving attention
and trying to trick them into ritualizing or avoiding. It is
also underscored that their most important task is to clearly
demonstrate that they are no longer willing to comply with
the demands of the OCD. This also includes zero tolerance
for rituals. All patients has in advance prepared suggestions for
exposure tasks, and during the last part of day one, each patient
presents their suggestions for the exposure tasks they think
will initiate the largest change. Typically, exposure tasks, which
combine different OCD-domains, are encouraged. The patients
are informed that this should be their last day with OCD, and that
they are not supposed to start ERP before the start of treatment on
day two. Each day includes some serving of fruit, biscuits, coffee
and tea, and day 2–4 patients and therapists share lunch, which is
also combined with summarizing progress.
On the second day, the group meets for approximately 8 h.
The day starts with a repetition of the principles for ERP, and
the patients are then given a chance to review their own lists of
exposure tasks from day one. The patients are introduced to the
LET-technique, which implies that the patients are encouraged to
do all exposures without any subtle avoidance, but instead lean
into the anxiety. They are encouraged to increase uncertainty
in situations where the OCD is demanding certainty. It is
specifically underscored that they should start paying attention
to exactly the moment when the OCD tempts them to start
ritualizing, since this is the moment when they can choose either
to comply with the OCD, or to do something incompatible with
the urge to reduce anxiety, uncertainty and discomfort. Anxiety
and discomfort are labeled the raw material for change and
something to be searching for in order to be able to practice
the LET-technique.
The patients are then split up into pairs with one certified 4-
day therapist per patient. The therapists work as a team, which
means that the patients may or may not be working with the same
therapist the 2 days of exposures. The LET-technique is practiced
in numerous relevant exposure tasks and settings with a therapist
as a coach. In the middle of the day, the group meets for lunch
and during the lunch the patients’ experiences are summarized.
This session is directed by the group leader and follows a strict
pattern where each patient share their progress with the group,
specifically focusing on whether they are using the LET-technique
fully. The patients rate their own performance on a scale from 1
to 6, where 6 indicates that they are leaning fully in. If the patients
give themselves a score of 5 or less, this is taken as an opportunity
for the group leader to explore the reasons for holding back, with
the intention of helping the patient to identify obstacles that can
be dealt with during the next session. The explicit goal for each
patient is to perform all exposure tasks in a way where they will
be able to give themselves a rating of 6. Since the leaning in
technique is based on a voluntary decision and intentional act,
this is a goal that is obtainable for all patients. This process is
also very transparent, since as a minimum of one therapist has
been observing and working with the patient. Anxiety is only
focused in terms of whether they were able to “find gold,” and
if not, the reasons are explored by the group leader. This session
follows directly after lunch (often when the group is still eating)
and typically last for 15–20 min.
During the second day, each patient should have worked
through their most important exposure tasks, especially the tasks
they anticipate to be most potent for creating change in their
lives. If the patient is unwilling to do exposures in some specific
and relevant settings, this is challenged by the therapist, and
the patient is highly recommended and encouraged to fight all
attempts and temptations from the OCD that in essence will
prevent them from regaining a normal life.
The group meets again at approximately 3:30 pm to
summarize and share their progress in the same manner as
at lunch. Together with their therapists, the patients make an
individually tailored plan for ERP for the evening, and these
exposures are typically self-administrated. Each patient reports
progress in at least one text message, typically sent to the therapist
at 9 pm. In this message they focus on how much they are “leaning
in” during the exposures on a scale from 1 to 6.
On the third day, the group meets for 8 h, with basically the
same outline and structure as day 2. After lunch, the patients
get the experience of employing the LET-technique without
assistance from the therapist. In the afternoon, the patients are
encouraged to invite relatives or important others for a lecture
about OCD, ERP, focused on how to support the patients in their
project of change. In addition, they have individualized exposure
plans for the evening, and report progress to the therapists by text
messages as the previous day.
On the fourth day, the group meets for approximately 4 h. The
last day starts with a summary of the previous evening. The focus
for the rest of the day is on how to maintain and continue the
changes the patients have made in their lives, and they are taught
principles for how to be their own therapist. Together with their
therapist each participant makes a day-to-day plan for further
exposure during the next 3 weeks. When they leave, they also get
an appointment 3 months ahead for a follow-up session (30 min)
which does not contain any ERP, but a repetition of the essential
components of the treatment.
For the following 3 weeks, the patients are encouraged to
report daily on how they are practicing the LET-technique. In
this pilot study, it was done with paper-and-pencil and sent
to the clinic once a week. The patients are informed that the
clinicians read the reports, but that there would be no contact
with the patients.
Therapists
The treatment was delivered in nine groups by a team of five
therapists; one psychiatrist and four psychologists. One of the
nine groups had three patients, seven had four patients, and one
group had five participants. The groups were allocated to pre-
specified time slots, and patients were included upon availability.
The therapists’ experience with OCD-treatment varied from
9 months to 15 years. Before the 4-day treatment was initiated,
three of the five therapists received hands-on training in two
B4DT groups led by the originators of the 4-day format, and
two therapists were trained in one group. Thus, the originators
participated as therapists in two of the 36 possible “therapist
slots.” In the first two groups, therapists from the originators’
team assisted and evaluated the competency of the novel
B4DT therapists.
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TABLE 2 | Means, standard deviations and effect sizes (Cohen’s d) for symptoms
of OCD, anxiety, and depression.
Pre Post Follow-up d post d F-U
Y-BOCS 26.74 (3.53) 10.87 (4.65) 9.97 (6.72) 4.50 4.75
DOCS-SF 26.09 (6.09) – 11.52 (7.96) – 2.39
OCI-R 25.24 (12.27) – 8.80 (8.22) – 1.34
GAD-7 12.02 (5.65) – 5.79 (4.17) – 1.10
PHQ-9 10.51 (6.05) 6.07 (5.99) 5.32 (4.46) 0.73 0.86
Cohen’s d: Mpre – Mpost/SDpre. Y-BOCS, Yale-Brown Obsessive Compulsive
Scale; DOCS-SF, Dimensional Obsessive-Compulsive Scale-Short Form; OCI-R,
Obsessive Compulsive Inventory-Revised; PHQ-9, Patient Health Questionnaire-9;
GAD-7, Generalized Anxiety Disorder-7.
Adherence and Competency
The psychoeducation is highly manualized with a set of power
point slides and accompanying text presented by the group
leader. This is also the case for the psychoeducation delivered to
the family. All participants (patients/family and therapists) have
their own handouts, to increase transparency and adherence.
As an important part of the format, brief therapist meetings
are pre-scheduled throughout each of the 4 days, in order to
enable adherence to the protocol, and also to give feedback to
each therapist regarding the way the treatment is delivered. In
addition, these meetings mean that all therapists are informed
about the progress and challenges for each patient, which is
a necessity in order to have more than one therapist working
with a given patient, when considered useful. As a rule-of-
thumb, the most experienced therapist works with the most
challenging patient, and also assists and supervises juniors. The
meetings also summarize how each therapist and patient work
with the LET-intervention.
Statistical Procedures
Repeated measures ANOVA were conducted to investigate
change in symptoms from pre- to post- and follow-up as
measured with Y-BOCS. Because the assumption of sphericity
was not met, as assessed by Mauchly’s test of sphericity,
χ2(2) = 7.65, p = 0.022, Greenhouse-Geisser correction was
applied. The assumption of sphericity was not violated for the
secondary outcome measures, therefore Wilks’ Lambda was used
for these analyses. For post-hoc analysis, Bonferroni corrections
were used. Effect sizes were calculated with Cohen’s d, defined
as (Mpre-Mpost)/SDpre. In order to allow participants with
missing data to be included in the analyses, missing data were
replaced using the expectation maximization (EM) method of
SPSS, version 24. When less than 25% of a data set is missing
and the data are missing at random, which was clearly the
case for this data set (Little’s MCAR test χ2(144) = 155.94,
p = 0.234), EM is an efficient method of replacing data, as
it requires no simulation of data sets (Schafer, 1997). There
was relatively low amount of missing data (6.7% for Y-BOCS
and 9.5% for the self-report measurements). We therefore
chose the EM algorithm over multiple imputations, as it is
suitable for conducting ANOVAs. For imputing the missing
data, outcome variables at each time point were included
(Schafer, 1997).
RESULTS
Results on primary and secondary treatment outcome measures
are presented in Table 2.
Primary Outcome Measures
A total of 27 (77.1%) patients had a Y-BOCS score of
24 or higher (moderate to severe OCD) at pre-treatment.
Only one patient had a Y-BOCS score above 16 at post-
treatment. There were significant changes in OCD severity,
F(1.657,56.342) = 159.95, p < 0.001, partial η2 = 0.825. The
change from pre-treatment to post-treatment was significant
(p < 0.001), whereas the change from post-treatment to follow-
up was not (p = 0.373). However, the change from pre- to
follow-up assessment was significant (p < 0.001), indicating
that the treatment effect was maintained from post-treatment
to follow-up. The self-report measures included showed similar
patterns. There were significant changes in OCD symptoms
as measured with the DOCS-SF, F(1,34) = 107.15, p < 0.001,
partial η2 = 0.759, and the OCI-R, F(1,34) = 92.60, p < 0.001,
partial η2 = 0.731.
Response and Remission Rates
Table 3 summarizes clinical improvement for the sample.
Only two patients (5.7%) were unchanged at post-treatment
whereas 33 (94.3%) showed a treatment response. A total
of 26 patients (74.3%) were classified as in remission. At
follow-up 20 % were unchanged and 80% showed a treatment
response. A total of 24 patients (68.6%) were classified as
in remission. Of the 26 patients who were in remission at
post-treatment, four changed status to unchanged at follow-up,
and two were classified as treatment responder. Of the seven
patients in the response category at post-treatment, four went
on to achieve remission, while one patient was classified at
unchanged at follow-up. The two patients that were classified
as unchanged at post-treatment were in the same category at
follow-up. None of the patients were classified as deteriorated
following treatment.
TABLE 3 | Clinical improvement at post-treatment and follow-up.
Status at follow-up, N (%)














Remission 20 (57.1) 2 (5.7) 4 (11.4) 26 (74.3)
Response 4 (11.4) 2 (5.7) 1 (2.9) 7 (20.0)
No change 0 (0.0) 0 (0.0) 2 (5.7) 2 (5.7)
Total 24 (68.6) 4 (11.4) 7 (20.0) 35 (100.0)
Treatment response was calculated based on the international consensus criteria
which requires a ≥35% reduction of the individual patient’s pre-treatment Y-BOCS
score in order to be classified as having a clinically relevant treatment response.
Patients classified as having a treatment response in Table 3 did not achieve
remission. A patient is classified as remitted if the post-treatment Y-BOCS score
is ≤12 points in addition to meeting criteria for treatment response. No patients
reported deterioration at post-treatment.
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Additional Comparisons
There were no significant post-treatment differences on
Y-BOCS between patients with moderate and severe OCD
at pre-treatment (Moderate: M = 8.56, SD = 2.03; Severe:
M = 11.55, SD = 5.00), t(33) = 1.64, p = 0.11, or at follow-up
(Moderate: M = 8.72, SD = 6.00; Severe: 10.34, SD = 6.98),
t(33) = 0.59, p = 0.53.
A total of 75% of patients with moderate severity were
remitted at follow-up compared to 66.7% of patients with severe-
extreme OCD. A total of 91% of patients without comorbid
disorders were in remission at follow-up compared to 58.3%
for patients with comorbidity (Fisher’s exact test, p = 0.12),
and the difference in Y-BOCS (Comorbidity: M = 11.45,
SD = 7.03, No-Comorbidity: M = 7.74, SD = 4.83) was
nearly significant, t(33) = 2.01, p = 0.053. Patients with
psychotropic medication did not differ on Y-BOCS compared
to patients without medication at pre-treatment, t(33) = 0.06,
p = 0.95, post-treatment, t(33) = 0.43, p = 0.67, or follow-up,
t(33) = 0.52, p = 0.61.
Secondary Outcome Measures
For depressive symptoms (PHQ-9), Mauchly’s test was
not significant (p = 0.119) and Wilks’ Lambda was used,
F(2,33) = 15.24, p < 0.001, partial η2 = 0.480. The change from
pre- to post-treatment was significant (p < 0.001), whereas the
change from post-treatment to follow-up was not (p = 0.474).
For depressive symptoms, 42.9% scored above the suggested
cut-off value of 11 on PHQ-9 at pre-treatment compared to
11.6% at follow-up.
For symptoms of generalized anxiety (GAD-7), there were
also significant reductions, F(1,34) = 44.56, p < 0.001, partial
η2 = 0.567. At pre-treatment 65.7% scored above the suggested
cut-off value of 10 compared to 20% at follow-up.
Treatment Satisfaction
Patients were highly satisfied with the treatment, as indicated by
a score of 29.5 (2.7) on the Client Satisfaction Questionnaire-8
where the maximum score is 32.
DISCUSSION
The aim of the current paper was to explore whether a
concentrated exposure based treatment, the B4DT, would yield
comparable results when delivered by new therapists at another
clinic, and the results obtained are nearly identical with the
results from the originators’ clinic. Treatment response rates
for the current study was 94% at post-treatment and 80% at
follow-up, while remission rates were 74% at post-treatment
and 69% at follow-up. As comparison, in the previous studies
on B4DT response rates range was 83–94% post-treatment
and 76–91% at follow-up, whereas remission rate range was
74–77% post-treatment and 60–77% at follow-up. Also, the
changes in self-reported depressive symptoms and in generalized
anxiety were in line with what has been reported from previous
effectiveness studies on the B4DT (Havnen et al., 2014, 2017;
Hansen et al., 2018a). Furthermore, the patients expressed high
satisfaction with all aspects of the B4DT format, including
the amount of treatment. There was also a very low dropout
rate (2.8%), which is approximately the same as previously
reported with 1.3% in Hansen et al. (2019) and 0% in
Hansen et al. (2018a).
Our clinic had substantial prior experience with group-
based ERP, and compared to our previous results the B4DT
was clearly superior. In our previous research (Håland et al.,
2010), we applied substantially more liberal criteria for response
(8 point reduction of pre-treatment Y-BOCS score), remission
(a score of ≤14 and the response criterion). When applying
these criteria on the current results, we find that only 2.9%
of the patients who received the B4DT were unchanged
following treatment compared to 51.9% of the patients in our
previous study (Fisher’s Exact Probability test, p < 0.001).
Also, in the current study with the B4DT 77.1% would have
been classified as in remission, compared to 33.3% in our
previous study (Fisher’s Exact Probability test, p < 0.001).
Furthermore, only 14.3% of the patients who received the
B4DT were unchanged at 3-month follow-up whereas the
corresponding rate for our previous group treatments was 38.9%,
which is also a significant difference (Fisher’s Exact Probability
test, p = 0.02).
One obvious advantage of the B4DT, also compared to
our previous 12-week intervention, is the ultra-concentrated
format with clearly defined start- and endpoint that are
agreed upon before the treatment is initiated. The fact that
the patients ahead of treatment have allocated four full days
to treatment, creates a highly change-focused atmosphere,
since everyone knows that each minute matters. Due to the
limited time, the patients were told that it is important to
start working with the tasks that are likely to be associated
with the largest change, and to combine as many different
OCD-aspects during the exposures as possible. This clearly
differs from our previous approach where the exposure
followed a hierarchy, starting with tasks that were expected
to elicit moderate discomfort, and then proceeding. Also,
in the B4DT, disconfirmation of OCD-beliefs are actively
replaced by the LET-intervention, where the ability to deal
with uncertainty is the main purpose. Furthermore, the B4DT
allows for individually tailored and therapist assisted exposure.
The former approach only had two therapists treating 5–
7 patients, and a substantial part of the exposures either
were illustrated by engaging one or two patients, or were
performed by the patients themselves without assistance from
a therapist, most often as a homework assignments. Another
important difference is the length of the sessions. Even though
the B4DT can be considered ultra-concentrated, the two
middle days actually can be seen as two prolonged exposure
sessions, which facilitates both repetition of and variation
in the therapist assisted exposures with the aim of making
the change robust.
A major difference between the B4DT and our former
approach addresses the attitude to anxiety and discomfort, where
the B4DT regards the anxiety as the raw material (“gold to
be digging for”) which is needed in order to obtain change as
opposed to something to be avoided. Patients are taught be aware
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of all the micro-choices where the OCD tempts them to start
to avoid or ritualize, and use these as opportunities to clearly
show that they are choosing to do something incompatible with
having OCD. By this, they learn a principle in dealing with
uncomfortable emotions, thoughts and situations, which can be
employed across settings. This approach to emotional regulation
differs clearly from the approach in the former group program,
where reduced anxiety and discomfort was seen as primary
treatment goals.
Another important aspect of the B4DT format is the
approach to training and adherence to the protocol, which are
pinpointed in the important paper “Mind the gap: Improving
the dissemination of CBT” by Shafran et al. (2009), as some
of the major challenges that need to be dealt with effectively
when disseminating treatments that work. Due to the 1:1 ratio
between therapists and patients in groups of 3–6 patients,
trainees can directly work with experts and receive feedback
and supervision, while they simultaneously can observe 3–6
patients with OCD going through major changes during only
4 days. While such an approach with direct observation of
experts combined with hands-on supervision is a cornerstone
when training surgeons, the approach is very rare in psychiatry.
Most therapists embrace the format and the opportunity
it serves for learning, but for some therapists the format
might be challenging, for example working with patients
full days, sharing lunch with them, and also be observed
directly by colleagues. In addition, the format requires the
therapist to be mobile and flexible while at the same time be
very focused. Furthermore, in order to be able to assist the
patient, the therapists themselves need to regard anxiety and
discomfort as gold and an opportunity for change as opposed
to something dangerous, and to have tolerance for the patient’s
discomfort and anxiety.
Limitations
Despite the fact that some of the therapists from the originators’
site participated in the first two groups, this study can be
seen as a successful step of systematic replication (Barlow
et al., 2009), in which the disorder and primary outcome
measure are the same but therapists and setting are new factors.
However, the lack of a research design with a control condition
obviously prevents firm conclusions related to causality, and
a randomized controlled trial where the B4DT is compared
to another treatment as well as to wait-list is warranted.
Given the research design, we are not able to conclude that
the B4DT is more effective than other treatments for OCD.
Also, there are clear limitations related to which parts of the
B4DT might be the most important for the clinical change
observed. The study is also limited by the lack of long-
term follow-up assessment. Future research should test if the
B4DT works for other anxiety disorders, and a pilot study on
panic disorder from our group has already shown promising
results (Hansen et al., 2018b). Future research should also
investigate the relationship between client satisfaction and
treatment outcome.
CONCLUSION
The main conclusion is that the B4DT format worked very well
at the clinic, and the results are nearly identical to those reported
from the originators’ clinic (Havnen et al., 2014, 2017; Hansen
et al., 2018a, 2019). Following this pilot study, the B4DT is now
the treatment of choice at our clinic, which also serves as a
training site for new clinics.
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